Kevin Hern: “I support that bill today and look forward to working with Congresswoman Meng to reintroduce it.”

I will always advocate for those who are suffering from a rare disease and support efforts to bring treatments for these diseases to market.

One way to do this is by reducing the regulatory burden so that Title IV-B funding recipients can spend more time helping children and families, and less time waiting through the red tape.

It is critical that we keep innovation here in the U.S., but it is also critical that we make sure healthcare is affordable.

I still think the right thing to do is to get our government under control. We’re $37 trillion in debt and growing.